Iterum Therapeutics Plc (ITRM) Tops Q2 EPS by 15c

Iterum Therapeutics Plc (NASDAQ: ITRM) reported Q2 EPS of ($0.30), $0.15 better than the analyst estimate of ($0.45).

For earnings history and earnings-related data on Iterum Therapeutics Plc (ITRM) click here.

You May Also Be Interested In

• Tesla Crash Into Texas Home Now Under Federal Safety Probe - WSJ
• Rocket Lab launches U.S. Space Force mission in record 16 hours
• Qualcomm (QCOM) PT Raised to $195 at BofA Securities